ketal tetradecane | 63947-34-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: ketal tetradecane
• 英文别名: Tetradecanediol；tetradecane-1,1-diol
• CAS: 63947-34-2
• 化学式: C₁₄H₃₀O₂
• 分子量: 230.391
• InChiKey: CQTBQILMJBCTRS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.7
• 重原子数：
  16
• 可旋转键数：
  12
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  aqueous perchloric acid 、 ketal tetradecane 、 1-dioxalane-cyclohexyl-4-spiroTHF 生成 1-噁螺[4.5]-8-癸酮
  参考文献：
  名称：

  摘要：

  DOI：

文献信息

• [EN] METHOD FOR PRODUCING AN AMINE<br/>[FR] PROCÉDÉ DE PRODUCTION D'UNE AMINE
  申请人：RHODIA OPERATIONS

  公开号：WO2020098937A1

  公开（公告）日：2020-05-22

  The invention relates to a method for producing an amine by reacting an alcohol, aldehyde and/or ketone with hydrogen and nitrogen-containing compound in the presence of a silver and/or ruthenium promoted cobalt catalyst. The nitrogen-containing compound is selected from ammonia, primary amines and secondary amines.

  这项发明涉及一种通过在存在银和/或钌促进的钴催化剂的情况下，将醇、醛和/或酮与氢气和含氮化合物反应来生产胺的方法。所述含氮化合物选自氨、一级胺和二级胺。
• Dye and ink jet printing ink
  申请人：KONICA MINOLTA HOLDINGS, INC.

  公开号：US20040106782A1

  公开（公告）日：2004-06-03

  A dye is disclosed, which is represented by the following formula: 1 wherein Z is an atomic group necessary to form a 6-membered nitrogen containing aromatic ring; R 11 is a hydrogen bonding group; R 12 , R 13 and R 14 are independently a hydrogen atom or a substituent; n11 and n13 are each an integer of 1 to 4; n12 is an integer of 1 to 3. There is also disclosed an ink for ink jet printing which contains the foregoing dye.

  揭示了一种染料，其表示为以下公式：1其中Z是形成一个含氮6元环芳香环所必需的原子基团；R11是一个氢键结合基团；R12、R13和R14分别是氢原子或取代基；n11和n13各自是1至4的整数；n12是1至3的整数。还披露了一种喷墨打印墨水，其中包含上述染料。
• Long chain diol diesters as low calorie fat mimetics
  申请人：NABISCO, INC.

  公开号：EP0405873A1

  公开（公告）日：1991-01-02

  Long chain diol diesters, notably 11- to 30- carbon aliphatic chains having two vicinal fatty acid esters or dicarboxylate-extended fatty acid esters, or two fatty acid esters or dicarboxylate-extended fatty acid esters separated by one or two methylene groups, attached to one end of the chain, are edible, preferably partially digestible, fat replacements for foods and pharmaceuticals.

  长链二醇双酯，尤其是具有两个邻近脂肪酸酯或二羧酸扩展脂肪酸酯的11-至30-碳链，或者具有两个脂肪酸酯或二羧酸扩展脂肪酸酯，其之间隔着一个或两个亚甲基基团，附着在链的一端，是食品和药品的可食用、部分可消化的脂肪替代品。
• Medical Adhesive
  申请人：Yoshimura Tetsuji

  公开号：US20070282093A1

  公开（公告）日：2007-12-06

  The present invention has its object to provide a medical adhesive excellent in safety, reactivity (curing rate) and duration of adhesive strength. A medical adhesive of the present invention comprises a hydrophilic urethane prepolymer (UP) obtained by reacting a fluorine-containing nonaromatic polyisocyanate component (A) and a polyol component (B) having a hydrophilic polyol (B 1 ) as the essential component, and a phenolic radical scavenger (PRS). The content of (PRS) is preferably 0.01 to 3% by weight based on the weight of (UP). The content of oxyethylene groups in (B) is preferably 30 to 100% by weight based on the weight of the oxyalkylene groups in (B). Preferably, (B) is a mixture of a random copolymer obtained by addition of ethylene oxide and propylene oxide to diols and polypropylene glycol. The content of isocyanate groups in the medical adhesive is 1 to 10% by weight based on the weight of (UP). The medical adhesive of the present invention is suitable for bonding body tissues, such as lung, artery and heart in particular.

  本发明的目的是提供一种在安全性、反应性（固化速率）和粘接强度持续时间方面具有优异性能的医用粘合剂。本发明的医用粘合剂包括通过反应含氟非芳香族多异氰酸酯组分（A）和具有亲水性多元醇（B1）作为基本组分的多元醇组分（B）获得的亲水性聚氨酯预聚物（UP）和酚类自由基清除剂（PRS）。根据（UP）的重量，（PRS）的含量优选为0.01至3重量％。根据（B）中氧乙烯基团的重量，氧乙烯基团的含量优选为30至100重量％。优选地，（B）是通过将环氧丙烷和丙烯酸酯添加到双醇和聚丙烯醇中获得的随机共聚物的混合物。医用粘合剂中异氰酸酯基团的含量根据（UP）的重量为1至10重量％。本发明的医用粘合剂特别适用于粘接肺、动脉和心脏等体内组织。
• [EN] ANTIMALARIAL AND ANTI-BABESIOSIS AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME<br/>[FR] AGENTS ANTIPALUDEENS ET ANTIBABESIOSES ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
  申请人：VIRBAC S.A.

  公开号：WO1998004252A1

  公开（公告）日：1998-02-05

  (EN) Pharmaceutical compositions having antimalarial and anti-babesiosis activity, the active principles of said compositions, and the use thereof for preparing antimalarial drugs, are disclosed.(FR) L'invention concerne des compositions pharmaceutiques ayant une activité antipaludéenne et antibabésiose, les principes actifs de ces compositions et leur utilisation dans l'obtention de médicaments anti-paludéens.

  具有抗疟疾和抗巴贝虫病活性的药物组合物，该组合物的活性成分以及用于制备抗疟疾药物的使用方法被揭示。